In this episode, we’re looking at the unique approach France has taken to try and get new and innovative treatments to patients faster, and what other national health bodies could learn from this process.

Joining us is an expert in market access and health policy, who has been at the forefront of recent regulatory changes in France and brings with her a wealth of knowledge from a career spanning three decades in pharmaceuticals.

This recording was organised and funded by Johnson & Johnson.

July 2024
CP460635